DDAH2 helps your body keep blood vessels relaxed by clearing away ADMA, a natural substance that can lower nitric oxide, a signal that supports healthy blood flow. When the DDAH2 gene works less well, ADMA may build up, which can reduce nitric oxide and may contribute to higher blood pressure, vessel stiffness, and heart or kidney problems. This gene plays an important role in how the lining of blood vessels responds to stress and inflammation.
What is a gene?
Genes are stretches of DNA that give your cells instructions they can use to make molecules or regulate processes in the body. Some genes hold the information needed to produce proteins, the working parts of cells. Others mainly help determine when certain processes happen, where they happen, and how strongly they run. Taken together, genes influence how the body develops and works, and they can shape how you respond to food, stress, or medications. If you want to look into this topic more deeply, you can learn more in the LearnHub.
Overview
DDAH2Gene function
What if the gene works
The DDAH2 gene helps break down ADMA, a natural substance that can reduce nitric oxide, a signal that helps blood vessels relax. This supports healthy vessel function and blood flow.
Risk
What if the gene does not work
Variants in the DDAH2 gene can range from milder to more severe and may reduce how well cells clear asymmetric dimethylarginine, a natural brake on nitric oxide signaling. This can disrupt nitric oxide control in blood vessel cells.
Treatment
What does that mean for your treatment
No treatment or drug choice is currently based on pathogenic variants in the DDAH2 gene. The DDAH2 gene is being studied as a possible biomarker and drug target in blood vessel and inflammatory conditions, but this has not entered routine care.
Gene function
What if the gene works
Your cells use the DDAH2 gene to help manage a natural chemical that can slow nitric oxide production. Nitric oxide is a small signaling molecule that helps blood vessels relax and supports routine cell communication. When DDAH2 works as expected, this system stays more balanced across many tissues.
The DDAH2 gene helps break down ADMA, a natural blocker of nitric oxide production. This keeps that blocker from building up too much in tissues.
By clearing ADMA, this gene helps regulate nitric oxide production in blood vessels and other tissues. That supports normal signaling that helps vessels relax and keeps circulation responsive.
DDAH2 supports everyday chemical messages that depend on nitric oxide. These signals help cells coordinate routine functions, especially where steady blood flow and vessel tone matter.
What is a variant?
Genetic variants are small differences in the DNA sequence of a gene. They are common and help make up normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change a gene’s function more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
How variants in the DDAH2 gene affect function depends on the DNA change: milder variants may partly alter the protein's shape, stability, or activity, while more severe variants can greatly lower protein levels or stop the enzyme from working. Some changes also disrupt RNA splicing (the cell's message editing step), which can lead to a shortened or unstable protein.
How variants are linked to conditions
The DDAH2 gene does not yet have a broadly confirmed link to a specific health condition, though this can change as research develops. Information on how variants of the DDAH2 gene are linked to conditions is still evolving, so anyone with a confirmed DDAH2-related finding should rely on guidance from their doctor or genetic counselor rather than general information.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widespread in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition points to a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some situations, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the DDAH2 gene. DDAH2 has been studied for possible links to blood vessel health and some common conditions, but these findings do not give clear, personal risk rules. Anyone worried about inherited risk can discuss it with a doctor or genetic counselor.
Inheritance of DDAH2 variants
There is not yet a broadly confirmed Mendelian pattern for how variants of the DDAH2 gene are inherited in relation to a specific human condition, so the answer to how variants of the DDAH2 gene are inherited remains cautious and research-based. The DDAH2 gene sits on chromosome 6, which is an autosome. That means each person usually has two copies of the DDAH2 gene, with one inherited from each parent.
What does my DDAH2 result mean for my family?
There is not yet a broadly confirmed pattern showing that changes in the DDAH2 gene cause a specific inherited condition in families. If you have a DDAH2 result and want to know what it could mean for relatives, a doctor or genetic counselor can explain it in the context of your own health and family history.
Genetic information
Genetic testing
How you find out about variants
In current practice, genetic testing for DDAH2 variants is usually done as part of a broader DNA test, often using a blood or saliva sample. A lab reads the DDAH2 gene to look for variants and reports whether a change was found, but results are interpreted alongside your symptoms, family history, and the rest of the test.
When should I consider getting a genetic test?
There is not yet a broadly established, DDAH2-specific reason for genetic testing in routine care. Decisions about testing are best made with a doctor or genetic counselor, based on your symptoms, medical history, and family history.
A genetic result is only one part of your health story
A genetic result can give useful insight, yet what it can tell you varies with the condition and with the kind of variant involved. How the body works over time is also shaped by many other factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other aspects of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down or transport a drug differently, so the same treatment may work better for one person, have less effect in another, or cause more side effects in someone else. These differences are common and help explain why medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape a person’s response to medications. It focuses on the relationship between genes and drugs to better understand why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can help support more informed, individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the DDAH2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how someone will respond to medicines. For side effects, concerns about a new prescription, or questions about whether a treatment is working as expected, it is best to speak with your doctor.
History
Research on DDAH2 grew out of work in the 1990s on nitric oxide, a signaling system that helped reshape vascular biology. In recent decades, awareness of this gene’s role has grown as scientists identified it as one of two closely related human DDAH genes. Early studies focused on mapping the gene and comparing it with the better known DDAH1 gene to understand how the family evolved and where each gene is active in the body. From these first observations, research expanded steadily into heart and blood vessel science, inflammation, and critical illness. DDAH2 has remained mainly a research gene rather than a public facing one, but it has contributed to a broader understanding of how inherited differences may influence nitric oxide related pathways.